Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5)

Lei Nie; Yongkun Wei; Fei Zhang; Yi-Hsin Hsu; Li Chuan Chan; Weiya Xia; Baozhen Ke; Cihui Zhu; Rong Deng; Jun Tang; Jun Yao; Yu Yi Chu; Xixi Zhao; Ye Han; Junwei Hou; Longfei Huo; How Wen Ko; Wan Chi Lin; Hirohito Yamaguchi; Jung-Mao Hsu; Yi Yang; Dean N. Pan; Jennifer L. Hsu; Celina G. Kleer; Nancy E. Davidson; Gabriel N. Hortobagyi; Mien Chie Hung

doi:10.1038/s41467-020-14429-3

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5)

Lei Nie, Yongkun Wei, Fei Zhang, Yi-Hsin Hsu, Li Chuan Chan, Weiya Xia, Baozhen Ke, Cihui Zhu, Rong Deng, Jun Tang, Jun Yao, Yu Yi Chu, Xixi Zhao, Ye Han, Junwei Hou, Longfei Huo, How Wen Ko, Wan Chi Lin, Hirohito Yamaguchi, Jung-Mao HsuYi Yang, Dean N. Pan, Jennifer L. Hsu, Celina G. Kleer, Nancy E. Davidson, Gabriel N. Hortobagyi, Mien Chie Hung

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

The original version of this Article omitted the following funding source from the Acknowledgements: CPRIT Research Training Program (RP101502, 140106, and 170067; to H.-W.K.). This has been corrected in the PDF and HTML versions of the Article.

Original language	English (US)
Article number	673
Journal	Nature communications
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/s41467-020-14429-3
State	Published - Dec 1 2020

ASJC Scopus subject areas

General Chemistry
General Biochemistry, Genetics and Molecular Biology
General Physics and Astronomy

Access to Document

10.1038/s41467-020-14429-3

Cite this

Nie, L., Wei, Y., Zhang, F., Hsu, Y.-H., Chan, L. C., Xia, W., Ke, B., Zhu, C., Deng, R., Tang, J., Yao, J., Chu, Y. Y., Zhao, X., Han, Y., Hou, J., Huo, L., Ko, H. W., Lin, W. C., Yamaguchi, H., ... Hung, M. C. (2020). Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5). Nature communications, 11(1), Article 673. https://doi.org/10.1038/s41467-020-14429-3

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5). / Nie, Lei ; Wei, Yongkun; Zhang, Fei et al.
In: Nature communications, Vol. 11, No. 1, 673, 01.12.2020.

Research output: Contribution to journal › Comment/debate › peer-review

Nie, L , Wei, Y, Zhang, F, Hsu, Y-H, Chan, LC, Xia, W, Ke, B, Zhu, C, Deng, R, Tang, J, Yao, J, Chu, YY, Zhao, X, Han, Y, Hou, J, Huo, L, Ko, HW, Lin, WC, Yamaguchi, H, Hsu, J-M, Yang, Y, Pan, DN, Hsu, JL, Kleer, CG, Davidson, NE, Hortobagyi, GN & Hung, MC 2020, 'Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5)', Nature communications, vol. 11, no. 1, 673. https://doi.org/10.1038/s41467-020-14429-3

@article{f78bf6c219504705a7330d1c203bf658,

title = "Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5)",

abstract = "The original version of this Article omitted the following funding source from the Acknowledgements: CPRIT Research Training Program (RP101502, 140106, and 170067; to H.-W.K.). This has been corrected in the PDF and HTML versions of the Article.",

author = "Lei Nie and Yongkun Wei and Fei Zhang and Yi-Hsin Hsu and Chan, {Li Chuan} and Weiya Xia and Baozhen Ke and Cihui Zhu and Rong Deng and Jun Tang and Jun Yao and Chu, {Yu Yi} and Xixi Zhao and Ye Han and Junwei Hou and Longfei Huo and Ko, {How Wen} and Lin, {Wan Chi} and Hirohito Yamaguchi and Jung-Mao Hsu and Yi Yang and Pan, {Dean N.} and Hsu, {Jennifer L.} and Kleer, {Celina G.} and Davidson, {Nancy E.} and Hortobagyi, {Gabriel N.} and Hung, {Mien Chie}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41467-020-14429-3",

language = "English (US)",

volume = "11",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5)

AU - Nie, Lei

AU - Wei, Yongkun

AU - Zhang, Fei

AU - Hsu, Yi-Hsin

AU - Chan, Li Chuan

AU - Xia, Weiya

AU - Ke, Baozhen

AU - Zhu, Cihui

AU - Deng, Rong

AU - Tang, Jun

AU - Yao, Jun

AU - Chu, Yu Yi

AU - Zhao, Xixi

AU - Han, Ye

AU - Hou, Junwei

AU - Huo, Longfei

AU - Ko, How Wen

AU - Lin, Wan Chi

AU - Yamaguchi, Hirohito

AU - Hsu, Jung-Mao

AU - Yang, Yi

AU - Pan, Dean N.

AU - Hsu, Jennifer L.

AU - Kleer, Celina G.

AU - Davidson, Nancy E.

AU - Hortobagyi, Gabriel N.

AU - Hung, Mien Chie

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The original version of this Article omitted the following funding source from the Acknowledgements: CPRIT Research Training Program (RP101502, 140106, and 170067; to H.-W.K.). This has been corrected in the PDF and HTML versions of the Article.

AB - The original version of this Article omitted the following funding source from the Acknowledgements: CPRIT Research Training Program (RP101502, 140106, and 170067; to H.-W.K.). This has been corrected in the PDF and HTML versions of the Article.

UR - http://www.scopus.com/inward/record.url?scp=85078664869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078664869&partnerID=8YFLogxK

U2 - 10.1038/s41467-020-14429-3

DO - 10.1038/s41467-020-14429-3

M3 - Comment/debate

C2 - 31996688

AN - SCOPUS:85078664869

SN - 2041-1723

VL - 11

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 673

ER -

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer (Nature Communications, (2019), 10, 1, (5114), 10.1038/s41467-019-13105-5)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this